Is leuprolide FDA-approved?

Yes, as specific products: Lupron Depot, Lupron Depot-PED, Eligard, Fensolvi, Camcevi and other leuprolide injections are FDA-approved for the uses in their labels, and they're prescription only.

Checked 1 Nov 2026. The sources are below.

Leuprolide

Also: leuprorelin, leuprolide acetate, Lupron Depot, Lupron Depot-PED, Eligard, Fensolvi, Camcevi, Vabrinty, Lutrate Depot, Lupron, Prostap, Enantone, Lucrin, TAP-144

Status label in the Peptimes Library
FDA Approved
Routes in Peptimes
IntramuscularSubcutaneous
Updated
1 Nov 2026

US regulatory status

FDA approval belongs to each product below, for its route and the uses in its label. Label uses are shortened unless quoted.

  • Lupron Depot (leuprolide acetate for depot suspension), the formulations labelled for prostate cancer

    Intramuscular

    Advanced prostate cancer.

    Source: DailyMed label, checked 1 Nov 2026

  • Lupron Depot (leuprolide acetate for depot suspension), the formulations labelled for endometriosis and fibroids

    Intramuscular

    Management of endometriosis, including pain relief and reduction of endometriotic lesions, and the other uses in its label.

    Source: DailyMed label, checked 1 Nov 2026

  • Lupron Depot-PED (leuprolide acetate for depot suspension)

    Intramuscular

    Central precocious puberty in children.

    Source: DailyMed label, checked 1 Nov 2026

  • Eligard (leuprolide acetate) injectable suspension

    Subcutaneous

    Advanced prostate cancer.

    Source: DailyMed label, checked 1 Nov 2026

  • Vabrinty (leuprolide acetate) injectable suspension

    Subcutaneous

    Advanced prostate cancer.

    Source: DailyMed label, checked 1 Nov 2026

  • Fensolvi (leuprolide acetate) injectable suspension

    Subcutaneous

    Central precocious puberty in children aged 2 and older.

    Source: DailyMed label, checked 1 Nov 2026

  • Camcevi (leuprolide) injectable emulsion

    Subcutaneous

    Advanced prostate cancer in adults.

    Source: DailyMed label, checked 1 Nov 2026

  • Leuprolide acetate for depot suspension, including Lutrate Depot

    Intramuscular

    Advanced prostate cancer.

    Source: DailyMed label, checked 1 Nov 2026

  • Generic leuprolide acetate injection, from several manufacturers

    Subcutaneous

    Palliative treatment of advanced prostate cancer, as stated on each product's label (approved through abbreviated new drug applications, ANDAs).

    Source: DailyMed label, checked 1 Nov 2026

  • Prescription

    Prescription only. Drugs@FDA lists each product above as "Prescription".

    Source: Drugs@FDA, checked 1 Nov 2026

  • Investigational

    No, for the products and uses above.

    Source: Drugs@FDA, checked 1 Nov 2026

How to track it in Peptimes

Add leuprolide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “FDA Approved”; the list above gives the detail by product.

  • Routes: intramuscular or subcutaneous. Choose the one that matches each dose.
  • Logging: the amount you took, the route and how you feel.
  • Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell leuprolide or any other compound.

More sources

Brand names on this page are trademarks of their owners. Peptimes isn't affiliated with or endorsed by them.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing